Aller au contenu principal
Profil bibliographique

Xiaohui Luan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

16Publications signalées
104Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Radiopharmaceutical Chemistry and ApplicationsHepatocellular Carcinoma Treatment and PrognosisProstate Cancer Treatment and ResearchRadiomics and Machine Learning in Medical ImagingProstate Cancer Diagnosis and Treatment

Les publications récentes

Accès ouvert 2026 article OpenAlex

Engineering carrier systems in targeted alpha therapy: Overcoming nuclear recoil and radiolysis for safer translation

Anqing Yan, Jiajia Zhang, Jin Yao, Shanshan Qin et autres

Targeted alpha therapy (TAT) has emerged as a highly potent modality in precision oncology. However, its clinical translation is hindered by unique radiobiological and pharmacological challenges. This review provides a structured overview of carrier systems used in TAT, including small molecules, peptides, …

cn (code pays fourni par la source)

0 citations Journal of Nuclear Medicine and Molecular Imaging
Accès ouvert 2026 article OpenAlex

A case of ischemia with non-obstructive coronary artery associated with coronary microvascular dysfunction diagnosed by coronary angiography and SPECT

Kaitao Wang, Han Zhang, Jiajia Zhang, S H I K A I Yu et autres

Ischemia with non-obstructive coronary artery disease (INOCA) is frequently driven by coronary microvascular dysfunction (CMD) but remains difficult to diagnose using conventional angiography alone. A 69-year-old female presented with typical chest pain. Coronary angiography (CAG) revealed no stenosis ≥ 50%, with slow …

cn (code pays fourni par la source)

0 citations Journal of Nuclear Medicine and Molecular Imaging
Accès ouvert 2025 article OpenAlex

Targeted alpha therapy: a comprehensive analysis of the biological effects from “local-regional-systemic” dimensions

Zhiling Song, Jiajia Zhang, Shanshan Qin, Xiaohui Luan et autres

Targeted alpha therapy (TAT) has emerged as a promising radiopharmaceutical modality in precision oncology. Compared to beta-emitters, alpha-emitters exhibit superior properties, including higher linear energy transfer, shorter penetration range, enhanced resistance to hypoxic conditions, and convenient radiation protection. Notably, alpha-emitters also demonstrate …

cn (code pays fourni par la source)

29 citations European Journal of Nuclear Medicine and Molecular Imaging
Accès ouvert 2025 article OpenAlex

Preclinical evaluation of [211At]At-AuNP-ABDMPL16 for targeted alpha therapy in Melanoma

Jiajia Zhang, Shanshan Qin, Xuhao Huang, Erina Hilmayanti et autres

The aim of this study is to overcome the challenges of poor tumor penetration and systemic toxicity in targeted alpha therapy (TAT) while also evaluating its immunomodulatory effects to enhance antitumor immune responses in melanoma treatment. This study developed a 211 At-labeled …

cn, jp (code pays fourni par la source)

3 citations European Journal of Nuclear Medicine and Molecular Imaging
2024 article OpenAlex

Layered Double Hydroxides for Radium‐223 Targeted Alpha Therapy with Elicitation of the Immune Response

Mengdie Yang, Jianguo Li, Xiaohui Luan, Xiaoyi Zhang et autres

Abstract Targeted Alpha therapy (TAT) has promising application prospects in tumor therapy. It is very appealing to design alpha‐emitting radiopharmaceuticals that can modulate the immune microenvironment to overcome the limitations of immunotherapy. Herein, Mg/Al layered double hydroxide nanomaterials (LDH) are utilized to …

cn (code pays fourni par la source)

10 citations Advanced Healthcare Materials
Accès ouvert 2024 article OpenAlex

Real-time diagnosis of sampled lesions in targeted biopsy of prostate Cancer using a novel tracer [64Cu] Cu-DOTA-PSMA-3Q: a pilot preclinical study

Jingfeng Zhang, Yachao Liu, Xiaohui Luan, Huanhuan Liu et autres

Prostate-specific membrane antigen positron emission tomography (PSMA-PET) guided targeted biopsy has shown potential for detecting more prostate cancer (PCa) cases. However, relying exclusively on imaging may risk missing lesions, an issue that could be addressed by incorporating radiation-guided technology. Accordingly, we aimed …

cn (code pays fourni par la source)

5 citations European Journal of Nuclear Medicine and Molecular Imaging
Accès ouvert 2024 article OpenAlex

The first-in-human preclinical evaluation of the new probe [123I]I-PSMA-7 for real-time intraoperative targeted biopsy and SPECT/CT imaging in prostate cancer

Xiaohui Luan, Shaoxi Niu, Yachao Liu, Xiaojun Zhang et autres

Abstract Purpose PSMA/PET has been increasingly used to detect PCa, and PSMA/PET-guided biopsy has shown promising results. However, it cannot be confirmed immediately whether the tissues are the targeted area. In this study, we aimed to develop a novel probe, [123I]I-PSMA-7. First, …

cn (code pays fourni par la source)

4 citations European Journal of Nuclear Medicine and Molecular Imaging
Accès ouvert 2023 article OpenAlex

Metabolic parameters of pretreatment 2-[18F]fluoro-D-glucose positron emission tomography for prognosis in patients with gallbladder adenocarcinoma: a cohort study

Can Li, Yanliang Dong, Yue Pan, Yun Han et autres

Background: F]FDG PET} parameters in predicting outcomes for patients with GBA. Methods: F]FDG PET/computed tomography (CT) before treatment were retrospectively analyzed at Chinese PLA General Hospital from January 2012 to June 2022. All patients were diagnosed by pathology, and their baseline characteristics …

cn (code pays fourni par la source)

2 citations Quantitative Imaging in Medicine and Surgery
Accès ouvert 2023 article OpenAlex

Multiparameter diagnostic model based on 18F-FDG positron emission tomography and serological examination for differentiating focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma

Guanyun Wang, Lei Du, Xia Lu, Shengxin Chen et autres

Background: 18F-fluorodeoxyglucose positron emission tomography-computerized tomography (18F-FDG PET-CT) has demonstrated high sensitivity in the diagnosis of autoimmune pancreatitis (AIP) and pancreatic ductal adenocarcinoma (PDAC), while also exhibiting the ability to distinguish AIP from PDAC lesions. The objective of this investigation was to …

cn (code pays fourni par la source)

5 citations Quantitative Imaging in Medicine and Surgery
Accès ouvert 2023 erratum OpenAlex

Corrigendum: The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy

Guanyun Wang, Wen‐Wen Zhang, Xiaohui Luan, Zhanbo Wang et autres

The original version of this article has been updated.In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement …

cn (code pays fourni par la source)

0 citations Frontiers in Immunology
Accès ouvert 2023 article OpenAlex

The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy

Guanyun Wang, Wenwen Zhang, Xiaohui Luan, Zhanbo Wang et autres

Purpose To investigate the diagnostic value of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET), as an imaging biomarker, for predicting pathological response and prognosis of unresectable hepatocellular carcinoma (HCC) patients treated with Lenvatinib and programmed cell death protein 1 (PD-1) inhibitors as a …

cn (code pays fourni par la source)

11 citations Frontiers in Immunology
Accès ouvert 2023 article OpenAlex

Multiparameter diagnostic model based on 18F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis

Can Li, Xiaohui Luan, Xiao Bi, Shengxin Chen et autres

Abstract Objective To evaluate the diagnostic value of a multiparameter model based on 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) metabolic parameters and clinical variables in differentiating nonmetastatic gallbladder cancer (GBC) from cholecystitis. Patients and methods In total, 122 patients (88 GBC nonmetastatic …

cn (code pays fourni par la source)

5 citations BMC Cancer

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.